ARCHIVES

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

This article is from The Cancer Letter archive.

Vol. 39 No. 08 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

Funding Opportunities

January 10, 2003

Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations.

April 28, 2006

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998